News & Articles
CoDa to Begin Clinical Trial
15 May 2008
CoDa Therapeutics has announced that it now has an open IND (Investigational New Drug application) after review by the US FDA (Food and Drug Administration)...
CoDa appoints Chief Operating Officer
28 February 2008
Auckland-based CoDaTherapeutics (NZ) Ltd. has announced the promotion of Tracey Sunderland to Chief Operating Officer...
CoDa Therapeutics Scoops First Deal of the Year
12 March 2007
Auckland biotech firm CoDa Therapeutics has received the inaugural NZBio Deal of the Year Award, in recognition of the company’s outstanding success over the past 12 months...
CoDa Completes US$20 Million Financing
23 February 2007
Biotechnology company CoDa Therapeutics has closed the second half of its initial round of venture capital funding, putting it on target to begin clinical trials...
CoDa secured $20 million of Series A VC funding from principal investors Domain Associates (Princeton, NJ; San Diego, CA) and GBS Ventures (Melbourne, Australia)
CoDaTherapeutics Secures US$10.0 Million in Additional Series A Financing
February 21 2007, 6:27 PM EST
Wound Healing Drug Development Company Will Use Funds to Achieve Clinical Development Milestones.
US Inestment for Wound Healing Drug
University of Auckland, 7 November 2006
A pioneering tissue repair drug discovered by a scientist at The University of Auckland working in collaboration with a colleague at University College London...
CoDaTherapeutics Announces Series A Financing
Oct 10 2006, 3:44 PM EST
SAN DIEGO, Oct. 10 /PRNewswire/ -- CoDa Therapeutics, Inc., a biopharmaceutical company founded in 2005, today announced the completion of a $10 million Series A preferred stock financing by Domain Associates...
